The U.S. will return treatments of the company’s Paxlovid drug as coronavirus vaccination rates fall.
Markets – MarketWatch
Pfizer Stock Drops After Guidance Cut. Investors Are Sizing Up the Company Post Covid-19. Markets – MarketWatch
Related Posts
Sellas Life Sciences Group Gets FDA Orphan Drug Designation to Treat Type of Leukemia Markets – MarketWatch
By Sabela Ojea Sellas Life Sciences Group said it received an orphan drug designation […]
This CD is paying a 7.19% APY — and 9 of the other best-paying CDs for October 2023 Markets – MarketWatch
Here’s what money pros say you need to know before making your first deposit. […]
Neogen 1Q Sales Rise While Profit Drops Markets – MarketWatch
By Dean Seal Neogen logged higher revenue but a smaller profit in its fiscal […]